These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18796425)

  • 21. Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units.
    Campino A; Santesteban E; Pascual P; Sordo B; Arranz C; Unceta M; Lopez-de-Heredia I
    Eur J Pediatr; 2016 Jun; 175(6):755-65. PubMed ID: 26670025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.
    Abdul-Aziz MH; Lipman J; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Dulhunty J; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Roberts JA;
    J Antimicrob Chemother; 2016 Jan; 71(1):196-207. PubMed ID: 26433783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous admixture service: implementation of service in a complex ICU patient population.
    Roof PS
    Hosp Pharm; 1989 Aug; 24(8):633-6, 638. PubMed ID: 10294359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incompatibilities in paediatric intensive care - pitfalls in drug information.
    Neininger MP; Buchholz P; Kiess W; Siekmeyer M; Bertsche A; Bertsche T
    Pharmazie; 2018 Oct; 73(10):605-608. PubMed ID: 30223926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prioritising the prevention of medication handling errors.
    Bertsche T; Niemann D; Mayer Y; Ingram K; Hoppe-Tichy T; Haefeli WE
    Pharm World Sci; 2008 Dec; 30(6):907-15. PubMed ID: 18787975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of adding piperacillin-tazobactam to automated dispensing cabinets on promptness of first-dose antibiotics in hospitalized patients.
    Lo A; Zhu JN; Richman M; Joo J; Chan P
    Am J Health Syst Pharm; 2014 Oct; 71(19):1663-7. PubMed ID: 25225451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients.
    Cuesta-López I; Sánchez-Cuervo M; Candela-Toha Á; Benedí-González J; Bermejo-Vicedo T
    Farm Hosp; 2018 Mar; 42(2):62-67. PubMed ID: 29501057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
    Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
    Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
    Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily serum piperacillin monitoring is advisable in critically ill patients.
    Blondiaux N; Wallet F; Favory R; Onimus T; Nseir S; Courcol RJ; Durocher A; Roussel-Delvallez M
    Int J Antimicrob Agents; 2010 May; 35(5):500-3. PubMed ID: 20226635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit.
    Gikic M; Di Paolo ER; Pannatier A; Cotting J
    Pharm World Sci; 2000 Jun; 22(3):88-91. PubMed ID: 11028261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compatibility of intravenous drugs in a coronary intensive care unit.
    Zeller FP; Anders RJ
    Drug Intell Clin Pharm; 1986 May; 20(5):349-52. PubMed ID: 3709346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem-cilastatin dosing intervention program by pharmacists.
    Newcomb HW; Hill EM; McCarthy ID; Mostow SR
    Am J Hosp Pharm; 1992 May; 49(5):1133-5. PubMed ID: 1595741
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients.
    Lee GC; Liou H; Yee R; Quan CF; Neldner K
    Clin Ther; 2012 Dec; 34(12):2297-300. PubMed ID: 23195962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug interactions in practice].
    Hoppe-Tichy T; Simon K; Hentze BW
    Ther Umsch; 2000 Sep; 57(9):563-7. PubMed ID: 11036436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospective assessment of medication errors in critically ill patients in a university hospital].
    Salazar L N; Jirón A M; Escobar O L; Tobar E; Romero C
    Rev Med Chil; 2011 Nov; 139(11):1458-64. PubMed ID: 22446651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine: a new paradigm to overcome drug incompatibilities.
    Abdelkader A; Fathi HA; Hamad MA; Elsabahy M
    J Pharm Pharmacol; 2020 Oct; 72(10):1289-1305. PubMed ID: 32436221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.